Fast patient
Proof of concept trials

PROOF OF CONCEPT TRIALS

proof of concept trials

ARENSIA delivers high degree of scientific and logistical expertise for Phase I/Ib/IIa and PROOF OF CONCEPT patient studies.

MORE

COVID-19 RESEARCH

COVID-19 RESEARCH

ARENSIA has contributed to numerous research projects with innovative compounds enrolling more than 1,500 COVID-19 patients.

MORE

REGULATORY PROCESS

regulatory process

ARENSIA has the know-how to successfully manage the regulatory process in various Eastern European countries.

MORE

PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) PATIENTS IN KYIV, UKRAINE

HOME · NEWS · PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) PATIENTS IN KYIV, UKRAINE

ARENSIA clinic in Kyiv started the New Year by administering an innovative drug to patients with paroxysmal nocturnal hemoglobinuria (PNH). Happy to share impressions of a patient visit to our clinic.

Among another 12 sites opened worldwide to contribute to this exciting trial, ARENSIA Ukraine is the first contributor to the project, starting screening 90 days after study submission in Ukraine and in 7 days after RALEC approval.

20.01.2023
VIDEO INTRO

We use technologies, such as cookies, and process personal data, such as IP addresses and cookie identifiers, to personalise content based on your interests, measure the performance of our content, and derive insights about the audiences who saw it. You can read more about our Cookie Policy here.

I accept I refuse